Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo’s Board of Directors in January 2027
Magwood’s experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets Magwood’s experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets
Covered in this story
What has happened since
- Nrc Health is down 4.7% since this was published, 7 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $NRC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nrc Health →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.